Abstract
The efficacy of NAPC in locally advanced PSCC was suggested in prior small case series. Although the phase III randomized InPACT trial is expected to report results for this disease space within the next 4 years, we are currently left with scant evidence-based guidance in managing these patients. Thus, we aimed to bridge that gap and provide evidence on real-world outcomes of patients with PSCC who received NAPC prior to surgical resection.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
